LU38816A1 - - Google Patents
Info
- Publication number
- LU38816A1 LU38816A1 LU38816DA LU38816A1 LU 38816 A1 LU38816 A1 LU 38816A1 LU 38816D A LU38816D A LU 38816DA LU 38816 A1 LU38816 A1 LU 38816A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US821720A US2966443A (en) | 1959-06-22 | 1959-06-22 | Trivalent poliomyelitis live virus vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU38816A1 true LU38816A1 (enrdf_load_html_response) | 1960-08-16 |
Family
ID=25234127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU38816D LU38816A1 (enrdf_load_html_response) | 1959-06-22 | 1960-06-14 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US2966443A (enrdf_load_html_response) |
| BE (1) | BE591268A (enrdf_load_html_response) |
| ES (1) | ES258463A1 (enrdf_load_html_response) |
| FR (1) | FR668M (enrdf_load_html_response) |
| LU (1) | LU38816A1 (enrdf_load_html_response) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3147185A (en) * | 1959-09-10 | 1964-09-01 | Merck & Co Inc | Process for purifying viral substances and composition |
| GB896439A (en) * | 1959-12-28 | 1962-05-16 | Glaxo Lab Ltd | Cellulose derivatives useful as anion-exchange materials and their application |
| US3244590A (en) * | 1960-12-23 | 1966-04-05 | Rutgers Res And Educational Fo | Polyenic compounds and procedures related thereto |
| US3143473A (en) * | 1961-08-16 | 1964-08-04 | Behringwerke Ag | Stable, solid, oral live antipoliomyelitis vaccine compositions and process for preparing them |
| DE1157734B (de) * | 1961-08-16 | 1963-11-21 | Behringwerke Ag | Verfahren zur Herstellung von haltbaren, oral zu verabreichenden Poliomyelitisvirus-Praeparaten |
| US3128229A (en) * | 1961-10-05 | 1964-04-07 | Baylor Medical Foundation | Stabilization of viral vaccine and inactivation of adventitious tissue culture contaminants therein |
| GB1015251A (en) * | 1963-03-12 | 1965-12-31 | Glaxo Lab Ltd | Aqueous pharmaceutical compositions in capsule form |
| GB1171125A (en) * | 1966-06-08 | 1969-11-19 | Glaxo Lab Ltd | Improvements in or relating to Injectable Preparations |
| MY128159A (en) * | 2000-06-30 | 2007-01-31 | Wyeth Corp | Methods and composition for oral vaccination |
-
1959
- 1959-06-22 US US821720A patent/US2966443A/en not_active Expired - Lifetime
-
1960
- 1960-05-27 BE BE591268A patent/BE591268A/fr unknown
- 1960-05-30 ES ES0258463A patent/ES258463A1/es not_active Expired
- 1960-06-14 LU LU38816D patent/LU38816A1/xx unknown
- 1960-09-20 FR FR830604A patent/FR668M/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BE591268A (fr) | 1960-11-28 |
| ES258463A1 (es) | 1960-11-16 |
| US2966443A (en) | 1960-12-27 |
| FR668M (enrdf_load_html_response) | 1961-07-10 |